Frontierby eninvs

Language: EN · RU

← Region

Kalbe Farma IDR

Update

Re-runs extraction for each period with period-end year from max(2023, current year − 2) through the current year, oldest first (up to three reporting years). This can take a long time.

Sector: Healthcare

ID_KLBF

Price chart

740 IDRDay 2.07%

Key metrics

Net debt (table and EV/EBITDA): |short-term borrowings| + |long-term borrowings| + |other financial liabilities| when extracted + |non-controlling interest| when extracted − |cash and equivalents|; amounts in millions of the reporting currency.

Market

Price
740 IDR · 2.07%
Market cap
33485.0 bn IDR

Growth

Δ revenue y/y
9.4%
Δ EBITDA y/y
-3.5%

Multiples

P/E (LTM)
9.3x
P/B (FY)
1.4x
EV/EBITDA (LTM)
6.1x

Cash return

Dividend yield
2.7%
FCF yield (LTM)
-0.0%

Value creation

fundamental value/yr, % of market cap
Value created / year
+8.3%
↓ details

Liquidity

Daily turnover (listing)
68.6 bln IDR

Shares: connector/market_inputs

🔍 Sanity check — subtotal consistency (Level-1 + Level-2) OK: 0 / Warn: 8 / Err: 1 / Autofix applied: 16
Port of PHP subtotal-total + sign-flip detection logic
PeriodIssues
2024-03-31 Q1⚠Warn 1
2024-06-30 H1⚠Warn 1
2024-09-30 9M⚠Warn 1
2024-12-31 FY⚠Warn 1Autofix 8
2025-03-31 Q1⚠Warn 1
2025-06-30 H1✗Errors 3Warn 1
2025-09-30 9M⚠Warn 1
2025-12-31 FY⚠Warn 1Autofix 8
2026-03-31 Q1⚠Warn 1
✓ All checks pass · ⚠ Has warnings (review) · ✗ Has errors (needs fix) · ✓* Autofix applied (see evidence)

Financial dynamics

Monetary columns are in B IDR, one decimal; scale (K/M/B/T) keeps values readable. For the period (default) shows P&L and cash flow for that row’s reporting window: quarterly amounts when the feed uses quarter-duration facts (typical US 10-Q revenue and income), quarterly cash flows after stripping YTD where only cumulative tags exist, and an implied Q4 on 31 Dec FY rows (P&L: FY minus Q1–Q3; operating / investing cash flow: FY 12m minus 9M YTD to 30 Sep when sourced from SEC builder evidence) so they match 10-Q scale. Some issuers still use cumulative YTD minus the prior row in the same calendar year. As reported shows values stored on each row (e.g. full-year on FY). Balance sheet is always as reported. Source JSON may use millions etc.; conversion uses amounts_unit per row.

DatePeriodStatusRevenueB IDROperating profitB IDRD&AB IDREBITDAB IDRNet profitB IDROperating CFB IDRCapex + M&AB IDRAssetsB IDREquityB IDRROE (annualized)Net debtB IDRSource
2026-03-31Q1 2026 (3M)OK9.7
y/y 9.4%
1.4
y/y -5.4%
0.2
y/y 11.8%
1.6
y/y -3.5%
1.0
y/y -4.4%
0.3-0.132.0
y/y 4.6%
25.7
y/y 1.5%
16.3%-4.1Report (PDF)
2025-12-31Q4 2025 (3M)OK9.3
y/y 11.3%
1.3
y/y 15.5%
0.2
y/y -5.4%
1.5
y/y 11.7%
1.0
y/y 19.9%
1.1-0.530.7
y/y 4.3%
24.7
y/y 0.6%
14.8%-4.0Report (PDF)
2025-09-30Q3 2025 (3M)OK8.9
y/y 7.2%
0.9
y/y 12.5%
0.2
y/y 2.5%
1.0
y/y 11.0%
0.7
y/y 10.6%
0.9-0.330.1
y/y 4.7%
24.8
y/y 3.7%
14.3%-3.5Report (PDF)
2025-06-30Q2 2025 (3M)OK8.2
y/y 4.6%
1.2
y/y 10.4%
0.2
y/y 2.0%
1.4
y/y 9.3%
0.9
y/y 9.4%
1.00.129.5
y/y 3.3%
24.2
y/y 2.8%
15.9%-3.0Report (PDF)
2025-03-31Q1 2025 (3M)OK8.8
y/y 5.8%
1.4
y/y 12.8%
0.2
y/y 0.9%
1.6
y/y 11.3%
1.1
y/y 12.4%
0.3-0.130.6
y/y 5.6%
25.4
y/y 5.2%
17.2%-4.0Report (PDF)
2024-12-31Q4 2024 (3M)OK8.4
y/y —
1.1
y/y —
0.2
y/y —
1.4
y/y —
0.9
y/y —
1.3-0.329.4
y/y —
24.6
y/y —
13.4%-4.2Report (PDF)
2024-09-30Q3 2024 (3M)OK7.9
y/y —
0.7
y/y —
0.2
y/y —
0.9
y/y —
0.6
y/y —
1.2-0.228.8
y/y —
23.9
y/y —
13.4%-3.4Report (PDF)
2024-06-30Q2 2024 (3M)OK8.0
y/y —
1.1
y/y —
0.2
y/y —
1.3
y/y —
0.8
y/y —
1.2-0.528.6
y/y —
23.5
y/y —
15.2%-2.7Report (PDF)
2024-03-31Q1 2024 (3M)OK8.4
y/y —
1.3
y/y —
0.2
y/y —
1.4
y/y —
1.0
y/y —
1.2-0.329.0
y/y —
24.1
y/y —
—-3.4Report (PDF)
Data quality No obvious scale, balance-sheet, or cash-flow sanity issues in the displayed periods.

Revenue & EBITDA

RevenueEBITDA

Quarterly values ($ mln)

02 0004 0006 0008 00010 0002024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q42026 q1

Year-over-year change

-5%0%5%10%15%2024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q42026 q1

Cash flow

FCF ($ mln)

02505007501 0002024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q42026 q1

Net debt / cash ($ mln)

-5 000-4 000-3 000-2 000-1 00002024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q42026 q1

Fundamental value creation

Value the company creates per year, as a % of market cap

Value created per year: +0.0%

How this was calculated
1. EBITDA growth (latest quarter YoY, annualised)
[EBITDA latest qtr − EBITDA year-ago qtr] × annualisation X
= —
-56
2. Current EV/EBITDA (LTM)
(Market cap + Net debt) ÷ EBITDA (LTM)
= (33 485 000 + -4 087) ÷ 5 506
30.0x — capped at 30x
3. Target multiple
(Current EV/EBITDA + 9) ÷ 2
= (30.0 + 9) ÷ 2
19.5x
4. Cash flow (balance method, LTM)
Net-debt reduction + dividends + buybacks − equity issuance
= —
3 190
5. Value created per year
(EBITDA growth × Target multiple + Cash flow − Dilution) ÷ Market cap
= (-56 × 19.5 + 3 190) ÷ 33 485 000
+0.0%

Amounts in millions of the reporting currency. EBITDA growth is the latest quarter vs the same quarter a year ago, annualised.

Caveats:

Dividends

Paid (completed)

DatePer shareDetailsStatusSource
2026-06-0420 IDREx-dividend: 20 IDR per sharePaidYahoo Finance (ex-div)
2025-06-0436 IDREx-dividend: 36 IDR per sharePaidYahoo Finance (ex-div)
2024-05-2931 IDREx-dividend: 31 IDR per sharePaidYahoo Finance (ex-div)
2023-05-1238 IDREx-dividend: 38 IDR per sharePaidYahoo Finance (ex-div)
2022-05-3135 IDREx-dividend: 35 IDR per sharePaidYahoo Finance (ex-div)

KASE: status follows wording in the news headline (paid vs intends to pay). Yahoo: amounts are cash dividends per share on ex-dividend dates (UTC calendar date). stockscope.uz (UZ): amounts are per share in UZS by publication date (not necessarily ex-div).

Investor reporting (IR): https://www.kalbe.co.id/investor-relations

Reporting forms detected in loaded periods: ✓ ✓ ✓ (Balance sheet / Profit or loss (P&L) / Cash flows)